Beauseigneur F, Goubern M, Chapey M F, Gresti J, Vergely C, Tsoko M, Demarquoy J, Rochette L, Clouet P
EA DRED 1867, Dijon, France.
Biochem J. 1996 Dec 1;320 ( Pt 2)(Pt 2):571-6. doi: 10.1042/bj3200571.
This study was designed to determine which enzyme activities were first impaired in mitochondria exposed to 2,2'-azobis-(2-amidinopropane) dihydrochloride (AAPH), a known radical initiator. EPR spin-trapping revealed generation of reactive oxygen species although malondialdehyde formation remained very low. With increasing AAPH concentrations, State-3 respiration was progressively depressed with unaltered ADP/O ratios. A top-down approach demonstrated that alterations were located at the phosphorylation level. As shown by inhibitor titrations, ATP/ADP translocase activity was unaffected in the range of AAPH concentrations used. In contrast, AAPH appeared to exert a deleterious effect at the level of F1F0-ATPase, comparable with dicyclohexylcarbodi-imide, which alters Fo proton channel. A comparison of ATP hydrolase activity in uncoupled and broken mitochondria reinforced this finding. In spite of its pro-oxidant properties, AAPH was shown to act as a dose-dependent inhibitor of cyclosporin-sensitive permeability transition initiated by Ca2+, probably as a consequence of its effect on F1F0-ATPase. Resveratrol, a potent antiperoxidant, completely failed to prevent the decrease in State-3 respiration caused by AAPH. The data suggest that AAPH, when used under mild conditions, acted as a radical initiator and was capable of damaging F1F0-ATPase, thereby slowing respiratory chain activity and reducing mitochondrial antioxidant defences.
本研究旨在确定在暴露于已知自由基引发剂2,2'-偶氮双-(2-脒基丙烷)二盐酸盐(AAPH)的线粒体中,哪些酶活性首先受到损害。电子顺磁共振自旋捕获显示尽管丙二醛形成仍然非常低,但仍产生活性氧。随着AAPH浓度的增加,状态3呼吸逐渐受到抑制,而ADP/O比值未改变。一种自上而下的方法表明,变化发生在磷酸化水平。如抑制剂滴定所示,在所用的AAPH浓度范围内,ATP/ADP转位酶活性未受影响。相反,AAPH似乎在F1F0-ATP酶水平上发挥有害作用,与改变Fo质子通道的二环己基碳二亚胺相当。对解偶联和破碎线粒体中ATP水解酶活性的比较强化了这一发现。尽管AAPH具有促氧化特性,但它被证明是一种对Ca2+引发的环孢素敏感的通透性转换具有剂量依赖性的抑制剂,这可能是其对F1F0-ATP酶作用的结果。白藜芦醇是一种有效的抗过氧化物,完全未能阻止AAPH引起的状态3呼吸的降低。数据表明,在温和条件下使用时,AAPH作为自由基引发剂,能够损害F1F0-ATP酶,从而减缓呼吸链活性并降低线粒体抗氧化防御能力。